Longview Acquisition II Debt/Equity Ratio 2021-2022 | LGV

Longview Acquisition II debt/equity ratio from 2021 to 2022. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Longview Acquisition II Debt/Equity Ratio 2021-2022 | LGV

Longview Acquisition II debt/equity ratio from 2021 to 2022. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$212.5B
Intuitive Surgical (ISRG)$180.7B
Alcon (ALC)$45.5B
Edwards Lifesciences (EW)$40B
IQVIA Holdings (IQV)$38.1B
IDEXX Laboratories (IDXX)$33.9B
DexCom (DXCM)$27.2B
Waters (WAT)$23B
STERIS (STE)$22.3B
SONOVA HOLDING (SONVY)$22B
Hologic (HOLX)$19.4B
Fresenius Medical Care AG KGaA (FMS)$11.8B
Sysmex ADR (SSMXY)$11.6B
Globus Medical (GMED)$10.1B
Teleflex (TFX)$9.6B
Penumbra (PEN)$8.8B
Masimo (MASI)$7.8B
Glaukos (GKOS)$7.2B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.2B
Inari Medical (NARI)$2.9B
TransMedics (TMDX)$2.9B
Veracyte (VCYT)$2.7B
LivaNova (LIVN)$2.7B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.2B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.9B
Alphatec Holdings (ATEC)$1.2B